INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Reg. 34 (1) Annual Report
Pursuant to Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit Annual Report of the Company for the financial year 2020-21. This is for your information and record. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Fixes Book Closure for AGM
Indraprastha Medical Corporation Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 18, 2021 to September 24, 2021 (both days inclusive) for the purpose of 33rd Annual General Meeting (AGM) of the Company to be held on September 24, 2021. Indraprastha Medical Corporation Ltd - 532150 - Board Meeting Outcome for Outcome Of The Board Meeting
This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 9th August, 2021 (i.e. today), inter-alia, considered and approved the following items: 1. Approved the re-appointment of Mr. P. Shivakumar (DIN : 08570283) as Managing Director, for a period of 3 years effective from 5th November, 2021 to 4th November, 2024, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company and such other approvals as may be necessary. 2. Approved convening the thirty-third Annual General Meeting (AGM) of the Company, on Friday, 24th September, 2021, through video conferencing and other audio visual means. 3. The Register of Members and Share Transfer Books of the Company shall remain closed from Saturday, 18th September, 2021 to Friday, 24th September, 2021 (both days inclusive) for the purpose of the AGM INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Unaudited Financial Results For The Quarter Ended 30Th June, 2021
This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 9th August, 2021 (i.e. today), inter-alia, considered and approved the following items: 1. Considered and approved the Un-audited Financial Results for the quarter ended 30th June, 2021, along with the Limited Review Report of the statutory auditor. 2. Approved the re-appointment of Mr. P. Shivakumar (DIN : 08570283) as Managing Director, for a period of 3 years effective from 5th November, 2021 to 4th November, 2024, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. 3. Approved convening the thirty-third Annual General Meeting (AGM) of the Company, on Friday, 24th September, 2021, through video conferencing and other audio visual means. 4. The Register of Members and Share Transfer Books of the Company shall remain closed from Saturday, 18th September, 2021 to Friday, 24th September, 2021 (both days inclusive) for the purpose of the AGM. Indraprastha Medical Corporation Ltd - 532150 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 30Th June, 2021
INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Monday, 9th August, 2021, to consider and approve, the unaudited financial results for the quarter ended 30th June, 2021. This is for your information and record. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Indraprastha Medical Corporation Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Postal Ballot - Voting Results And Report Of Scrutinizer
We wish to inform you that the Company has conducted the process of Postal Ballot for seeking approval of its shareholders by way of Postal Ballot voting (only through e-voting) for the businesses as set out in the Postal Ballot notice dated 9th June, 2021. The voting ended on 23rd July, 2021. In this regard, enclosed please find the following- (1) Voting results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations - Annexure - I; and (2) Report of Scrutinizer dated 24th July, 2021, pursuant to Section 108 of the Companies Act, 2013, read with the Companies (Management and Administration) Rules, 2014 - Annexure- II. This is for your information and records. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, enclosed please find herewith a Certificate dated 5th July, 2021, issued by M/s. Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company, for the quarter ended 30th June, 2021. This is for your information and record. Indraprastha Medical Corporation Ltd - 532150 - Shareholding for the Period Ended June 30, 2021
Indraprastha Medical Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0770 Name of the Signatory :- PRIYA RANJANDesignation :- Company Secretary and Compliance Officer